Author | Jason Harris

Articles

Combination Therapy With Cabozantinib and Atezolizumab Gains Foothold in Urothelial Carcinoma

May 30, 2020

Article

Patients with urothelial carcinoma who progress after platinum-containing chemotherapy may receive benefit with the combination regimen of cabozantinib and atezolizumab, according to new data from the COSMIC-021 study.

Pembrolizumab Increases 24-Month PFS2 in PD-L1+ HNSCC

May 30, 2020

Article

Overall, these data support the use of pembrolizumab and pembrolizumab plus chemotherapy as first-line treatment of patients with relapsed and/or metastatic HNSCC.

Overall Survival Not Increased With Locoregional Therapy in Advanced Breast Cancer

May 28, 2020

Article

"Based on the results of our study, women who present with a new diagnosis of breast cancer already in stage IV should not be offered surgery and radiation for the primary breast tumor with the expectation of a survival benefit."

COVID-19 Mortality Shows Strong Correlation With Active Cancer

May 28, 2020

Article

The risk for death from COVID-19 was greater for patients with stable cancer compared with patients who had no evidence of disease.